Arizona State Retirement System Sells 6,790 Shares of Danaher Corporation $DHR

Key Points

• Arizona State Retirement System trimmed its stake in Danaher by 3.6%, selling 6,790 shares and ending the quarter with 181,341 shares valued at about $41.51 million.
• Danaher beat Q1 non‑GAAP EPS ($2.06 vs. $1.94) and nudged FY26 adjusted EPS guidance higher while raising the quarterly dividend to $0.40, but revenue missed estimates and the company faces near‑term headwinds including Diagnostics softness, a $172.5M shareholder settlement and a large euro‑denominated notes offering.
• Analyst sentiment is mostly positive (17 Buys, 3 Holds) with a consensus target of $242.45, yet several firms have recently cut price targets and the stock traded down to about $178.72, near its one‑year low.

Arizona State Retirement System decreased its position in shares of Danaher Corporation (NYSE:DHR - Free Report) by 3.6% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 181,341 shares of the conglomerate's stock after selling 6,790 shares during the period. Arizona State Retirement System's holdings in Danaher were worth $41,513,000 at the end of the most recent quarter.

Several other large investors have also recently added to or reduced their stakes in the company. Wealth Science Advisors LLC bought a new position in Danaher during the 4th quarter worth $279,000. Quent Long Short Global Small Cap Fund LP bought a new position in Danaher during the 4th quarter worth $655,000. Cornerstone Advisory LLC increased its position in Danaher by 19.3% during the 4th quarter. Cornerstone Advisory LLC now owns 1,913 shares of the conglomerate's stock worth $438,000 after buying an additional 309 shares during the period. Turtle Creek Wealth Advisors LLC increased its stake in Danaher by 55.4% during the 4th quarter. Turtle Creek Wealth Advisors LLC now owns 3,715 shares of the conglomerate's stock worth $850,000 after acquiring an additional 1,325 shares during the period. Finally, waypoint wealth counsel increased its stake in Danaher by 24.6% during the 4th quarter. waypoint wealth counsel now owns 2,829 shares of the conglomerate's stock worth $648,000 after acquiring an additional 559 shares during the period. Institutional investors own 79.05% of the company's stock.

Wall Street Analysts Forecast Growth

DHR has been the topic of a number of recent research reports. The Goldman Sachs Group lowered their price objective on Danaher from $265.00 to $230.00 and set a "buy" rating on the stock in a research note on Monday, April 13th. Morgan Stanley lowered their price objective on Danaher from $270.00 to $255.00 and set an "overweight" rating on the stock in a research note on Wednesday. UBS Group lowered their price objective on Danaher from $270.00 to $250.00 and set a "buy" rating on the stock in a research note on Wednesday. Leerink Partners raised their price objective on Danaher from $260.00 to $270.00 and gave the stock an "outperform" rating in a research note on Friday, January 16th. Finally, Evercore raised their price objective on Danaher from $225.00 to $232.00 and gave the stock an "outperform" rating in a research note on Tuesday. Seventeen research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus target price of $242.45.

Danaher Trading Down 2.9%

Shares of Danaher stock opened at $178.72 on Friday. The firm has a market capitalization of $126.49 billion, a PE ratio of 34.57, a price-to-earnings-growth ratio of 2.50 and a beta of 0.95. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.33. The firm's 50 day moving average is $196.45 and its 200 day moving average is $214.10. Danaher Corporation has a 1 year low of $175.00 and a 1 year high of $242.80.

Danaher (NYSE:DHR - Get Free Report) last announced its quarterly earnings results on Tuesday, April 21st. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.94 by $0.12. The company had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm's revenue was up 3.7% on a year-over-year basis. During the same period in the previous year, the firm posted $1.88 EPS. Danaher has set its FY 2026 guidance at 8.350-8.550 EPS. Equities research analysts forecast that Danaher Corporation will post 8.4 earnings per share for the current fiscal year.

Danaher Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be given a dividend of $0.40 per share. The ex-dividend date is Friday, March 27th. This represents a $1.60 dividend on an annualized basis and a yield of 0.9%. This is an increase from Danaher's previous quarterly dividend of $0.32. Danaher's dividend payout ratio is presently 30.95%.

Key Danaher News

Here are the key news stories impacting Danaher this week:

• Positive Sentiment: Q1 EPS beat and slight raise to FY EPS range — Danaher beat non‑GAAP EPS estimates ($2.06 vs. consensus) and nudged full‑year adjusted EPS guidance higher, which supports earnings visibility. Earnings Call Highlights
• Positive Sentiment: Bioprocessing momentum and M&A strategy remain drivers — management highlighted strength in bioprocessing and the acquisition pipeline as long‑term growth levers. Q1 Deep Dive
• Neutral Sentiment: Large euro‑denominated senior‑notes offering (~€2.98B net proceeds) — the deal finances operations and transactions but increases liabilities; market reaction depends on how proceeds are used. Notes Offering
• Neutral Sentiment: Masimo acquisition: longer‑term optionality vs. near‑term integration/earnings pressure — analysts note the deal adds strategic upside but may weigh on near‑term returns and capital allocation. Masimo Analysis
• Negative Sentiment: $172.5M shareholder settlement over post‑pandemic demand disclosures — a material cash charge and reputational headwind that increases near‑term litigation/expense risk. Settlement Report
• Negative Sentiment: Revenue miss and Diagnostics softness weighed on the print — core revenue growth was modest and Diagnostics showed weakness (lighter respiratory season at Cepheid), which undercut the EPS beat. Revenue/Segment Notes
• Negative Sentiment: Multiple analyst price‑target cuts (Morgan Stanley, JPMorgan, Wells Fargo, Guggenheim, UBS among others) — downgrades and lower targets increase downside pressure and reduce near‑term analyst support. Morgan Stanley PT Cut

Insiders Place Their Bets

In other news, EVP Gregory M. Milosevich sold 1,320 shares of the business's stock in a transaction dated Thursday, February 19th. The stock was sold at an average price of $208.01, for a total transaction of $274,573.20. Following the sale, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. The trade was a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. 10.80% of the stock is owned by corporate insiders.

About Danaher

Danaher Corporation NYSE: DHR is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher's portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corporation (NYSE:DHR - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.